May 7, 2012
Foreign-affiliated pharmaceutical manufacturers have announced their settlements of accounts for 2011. Though deteriorating healthcare finances are putting growing pressure on drug prices worldwide, these companies recorded double-digit growth in sales in Japan as well as in newly emerging markets. The...read more